Amgen has given a much-anticipated first look at Lumakras’ combination with checkpoint inhibitors. As many industry watchers have feared, the pairing raised a safety red flag that the efficacy results ...
Lung cancer screening experts from around the globe delivered strategies and best practices for improving access to screening and facilitating earlier detection at the 2024 World Conference on Lung ...
A mid-stage trial of Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan has hit the mark and will form the basis of regulatory filings for the drug later this year. The ...
Johnson & Johnson’s EGFR-MET bispecific antibody is padding its case ahead of a potential FDA nod. The drug shrank tumors in 40% of lung cancer patients with a rare EGFR mutation and curbed tumor ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Data from the phase Ib Beamion LUNG-1 trial selected for late-breaking oral presentation in the Presidential Symposium at WCLC on Monday, September 9. The U.S. FDA and China's CDE have granted ...
Chairs and presenters from the 2024 World Conference on Lung Cancer comment on their favorite parts about attending this meeting each year. As the 2024 World Conference on Lung Cancer (WCLC) came to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results